O'Neill Vincent has filed 31 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 1875 shares of BioXcel Therapeutics, Inc. ($BTAI) on July 22, 2024.
Activity breakdown: 0 open-market purchases and 7 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 22, 2024 | BioXcel Therapeutics, Inc. | $BTAI | O'Neill Vincent | Other | A | Stock Option (right to buy) | 1875 | $0.00 | 1,875.0000 | 2,516,000 | 9999.99% | 0.07% |
| Dec. 14, 2024 | BioXcel Therapeutics, Inc. | $BTAI | O'Neill Vincent | See Remarks | M | Common Stock | 521 | $0.00 | 20,122.0000 | 2,649,000 | 2.66% | 0.02% |
| Dec. 16, 2024 | BioXcel Therapeutics, Inc. | $BTAI | O'Neill Vincent | See Remarks | S | Common Stock | 165 | $0.35 | 19,957.0000 | 2,649,000 | 0.82% | 0.01% |
| Dec. 14, 2024 | BioXcel Therapeutics, Inc. | $BTAI | O'Neill Vincent | See Remarks | M | Restricted Stock Units | 521 | $0.00 | 2,606.0000 | 2,649,000 | 16.66% | 0.02% |
| Sept. 17, 2024 | BioXcel Therapeutics, Inc. | $BTAI | O'Neill Vincent | See Remarks | A | Common Stock | 21250 | $0.00 | 25,157.0000 | 2,516,000 | 543.90% | 0.84% |
| Oct. 3, 2024 | BioXcel Therapeutics, Inc. | $BTAI | O'Neill Vincent | See Remarks | S | Common Stock | 5556 | $0.55 | 19,601.0000 | 2,649,000 | 22.09% | 0.21% |
| Sept. 14, 2024 | BioXcel Therapeutics, Inc. | $BTAI | O'Neill Vincent | See Remarks | M | Common Stock | 521 | $0.00 | 4,045.0000 | 2,516,000 | 14.78% | 0.02% |
| Sept. 16, 2024 | BioXcel Therapeutics, Inc. | $BTAI | O'Neill Vincent | See Remarks | S | Common Stock | 138 | $0.69 | 3,907.0000 | 2,516,000 | 3.41% | 0.01% |
| Sept. 14, 2024 | BioXcel Therapeutics, Inc. | $BTAI | O'Neill Vincent | See Remarks | M | Restricted Stock Units | 521 | $0.00 | 3,127.0000 | 2,516,000 | 14.28% | 0.02% |
| June 14, 2024 | BioXcel Therapeutics, Inc. | $BTAI | O'Neill Vincent | See Remarks | M | Common Stock | 521 | $0.00 | 3,679.0000 | 1,929,000 | 16.50% | 0.03% |
| June 17, 2024 | BioXcel Therapeutics, Inc. | $BTAI | O'Neill Vincent | See Remarks | S | Common Stock | 155 | $1.29 | 3,524.0000 | 1,929,000 | 4.21% | 0.01% |
| June 14, 2024 | BioXcel Therapeutics, Inc. | $BTAI | O'Neill Vincent | See Remarks | M | Restricted Stock Units | 521 | $0.00 | 3,648.0000 | 1,929,000 | 12.50% | 0.03% |
| March 14, 2024 | BioXcel Therapeutics, Inc. | $BTAI | O'Neill Vincent | See Remarks | M | Common Stock | 521 | $0.00 | 3,323.0000 | 1,821,000 | 18.59% | 0.03% |
| March 15, 2024 | BioXcel Therapeutics, Inc. | $BTAI | O'Neill Vincent | See Remarks | M | Common Stock | 2250 | $0.00 | 5,573.0000 | 1,821,000 | 67.71% | 0.12% |
| April 4, 2024 | BioXcel Therapeutics, Inc. | $BTAI | O'Neill Vincent | See Remarks | S | Common Stock | 165 | $2.62 | 5,408.0000 | 1,929,000 | 2.96% | 0.01% |
| March 14, 2024 | BioXcel Therapeutics, Inc. | $BTAI | O'Neill Vincent | See Remarks | M | Restricted Stock Units | 521 | $0.00 | 4,169.0000 | 1,821,000 | 11.11% | 0.03% |
| March 15, 2024 | BioXcel Therapeutics, Inc. | $BTAI | O'Neill Vincent | See Remarks | M | Restricted Stock Units | 2250 | $0.00 | 6,750.0000 | 1,821,000 | 25.00% | 0.12% |
| Dec. 14, 2023 | BioXcel Therapeutics, Inc. | $BTAI | O'Neill Vincent | Chief Medical Officer | M | Common Stock | 521 | $0.00 | 2,802.0000 | 29,268,000 | 22.84% | 0.00% |
| Dec. 14, 2023 | BioXcel Therapeutics, Inc. | $BTAI | O'Neill Vincent | Chief Medical Officer | M | Restricted Stock Units | 521 | $0.00 | 4,690.0000 | 29,268,000 | 10.00% | 0.00% |
| Sept. 14, 2023 | BioXcel Therapeutics, Inc. | $BTAI | O'Neill Vincent | Chief Medical Officer | M | Common Stock | 521 | $0.00 | 2,281.0000 | 29,187,000 | 29.60% | 0.00% |
| Sept. 14, 2023 | BioXcel Therapeutics, Inc. | $BTAI | O'Neill Vincent | Chief Medical Officer | M | Restricted Stock Units | 521 | $0.00 | 5,211.0000 | 29,187,000 | 9.09% | 0.00% |
| June 14, 2023 | BioXcel Therapeutics, Inc. | $BTAI | O'Neill Vincent | Chief Medical Officer | M | Common Stock | 521 | $0.00 | 1,760.0000 | 28,616,000 | 42.05% | 0.00% |
| June 14, 2023 | BioXcel Therapeutics, Inc. | $BTAI | O'Neill Vincent | Chief Medical Officer | M | Restricted Stock Units | 521 | $0.00 | 5,732.0000 | 28,616,000 | 8.33% | 0.00% |
| March 14, 2023 | BioXcel Therapeutics, Inc. | $BTAI | O'Neill Vincent | Chief Medical Officer | M | Common Stock | 2084 | $0.00 | 2,084.0000 | 28,015,000 | 9999.99% | 0.01% |
| March 15, 2023 | BioXcel Therapeutics, Inc. | $BTAI | O'Neill Vincent | Chief Medical Officer | S | Common Stock | 845 | $19.70 | 1,239.0000 | 28,015,000 | 40.55% | 0.00% |
| March 14, 2023 | BioXcel Therapeutics, Inc. | $BTAI | O'Neill Vincent | Chief Medical Officer | M | Restricted Stock Units | 2084 | $0.00 | 6,253.0000 | 28,015,000 | 25.00% | 0.01% |
| March 15, 2023 | BioXcel Therapeutics, Inc. | $BTAI | O'Neill Vincent | Chief Medical Officer | A | Restricted Stock Units | 9000 | $0.00 | 9,000.0000 | 28,015,000 | 9999.99% | 0.03% |
| March 15, 2023 | BioXcel Therapeutics, Inc. | $BTAI | O'Neill Vincent | Chief Medical Officer | A | Stock Option (Right to Buy) | 32000 | $0.00 | 32,000.0000 | 28,015,000 | 9999.99% | 0.11% |
| Jan. 20, 2023 | BioXcel Therapeutics, Inc. | $BTAI | O'Neill Vincent | Chief Medical Officer | M | Common Stock | 29713 | $0.41 | 29,713.0000 | 28,015,000 | 9999.99% | 0.11% |
| Jan. 20, 2023 | BioXcel Therapeutics, Inc. | $BTAI | O'Neill Vincent | Chief Medical Officer | S | Common Stock | 29713 | $30.00 | 0.0000 | 28,015,000 | 100.00% | 0.11% |
| Jan. 20, 2023 | BioXcel Therapeutics, Inc. | $BTAI | O'Neill Vincent | Chief Medical Officer | M | Employee Stock Option (right to buy) | 29713 | $0.00 | 29,712.0000 | 28,015,000 | 50.00% | 0.11% |